Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Apply
TGFβR2KO/IL13Rα2 CAR T-Cells
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step